CompletedPhase 4

Moxifloxacin in Situ Gel to Treat Periodontal Pocket.

India5 participantsStarted 2011-09

Plain-language summary

In this Randomized clinical trial locally delivered moxifloxacin in situ gel was evaluated as an adjunct to scaling and root planing for efficacy in the treatment of chronic periodontitis and for short-term effects on the periodontal microflora.

Who can participate

Age range25 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with good systemic health * Patients with Chronic periodontitis with sites with probing pocket depth (PPD) of ≥ 5 mm * a minimum of 12 natural teeth with radiographic evidence of bone loss * willingness to comply with the study protocol. Exclusion Criteria: * Patients with a history of drug allergy to quinolones or those who were taking medication that might interact with moxifloxacin * Patients with history of antibiotic coverage in the 6 months preceding the study * Pregnant or lactating patients.

What they're measuring

Change from baseline in Clinical attachment level at 3 months in chronic periodontitis patients

Timeframe: 3 months

Trial details

NCT IDNCT02016157

SponsorSri Hasanamba Dental College and Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-11

View on ClinicalTrials.gov More Chronic Generalized Periodontitis trials